Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Aleš Ambrožič"'
Publikováno v:
Zdravniški Vestnik, Vol 91, Iss 11-12, Pp 534-538 (2022)
V Sloveniji kljub pomanjkanju revmatologov in s tem daljšimi čakalnimi dobami revmatološkim bolnikom zagotavljamo sodobno obravnavo, ki je primerljiva z delom v najbolj priznanih svetovnih ustanovah. Da visoko raven obravnave tudi vprihodnosti ohr
Externí odkaz:
https://doaj.org/article/ad241a04e8f54862b8209a2aa44ab80a
Autor:
Ula Štok, Neža Štucin, Elizabeta Blokar, Aleš Ambrožič, Snežna Sodin-Šemrl, Saša Čučnik, Polona Žigon
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2341 (2022)
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by thrombosis and/or obstetric complications in the presence of antiphospholipid antibodies (aPL). Catastrophic APS (CAPS) is the most severe form of the disease, in whic
Externí odkaz:
https://doaj.org/article/4a9becd280e54265b8545aa01dcef8bc
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
We herein report two cases of primary adrenal insufficiency (AI) associated with antiphospholipid syndrome (APS). In both patients, the main finding that led to the diagnosis was hyponatraemia. The major difference between the two cases was the time
Externí odkaz:
https://doaj.org/article/a2a3011a1ee3429e9fc574d6b9d46b66
Autor:
Katja Perdan-Pirkmajer, Polona Žigon, Anja Boc, Eva Podovšovnik, Saša Čučnik, Alenka Mavri, Žiga Rotar, Aleš Ambrožič
Publikováno v:
Biomedicines, Vol 9, Iss 8, p 901 (2021)
Antiphospholipid syndrome (APS) is an important cause of deep vein thrombosis (DVT). According to current APS classification criteria, APS cannot be confirmed until 24 weeks after DVT. This time frame results in frequent discontinuation of anticoagul
Externí odkaz:
https://doaj.org/article/96d1adfa744343d2bbbdabe205704cca
Autor:
Ula Štok, Elizabeta Blokar, Metka Lenassi, Marija Holcar, Mojca Frank-Bertoncelj, Andreja Erman, Nataša Resnik, Snežna Sodin-Šemrl, Saša Čučnik, Katja Perdan Pirkmajer, Aleš Ambrožič, Polona Žigon
Publikováno v:
Cells, Vol 9, Iss 5, p 1211 (2020)
Antiphospholipid syndrome (APS) is a systemic autoimmune disease, characterized by thrombosis, obstetric complications and the presence of antiphospholipid antibodies (aPL), which drive endothelial injury and thrombophilia. Extracellular vesicles (EV
Externí odkaz:
https://doaj.org/article/530ce4a21c684e30abfcb6af43546012
Publikováno v:
Zdravniški Vestnik, Vol 84, Iss 3 (2015)
In patients with the antiphospholipid syndrome (APS), the presence of a group of pathogenic autoantibodies called antiphospholipid antibodies causes thrombosis and pregnancy complications. The most frequent antigenic target of antiphospholipid antibo
Externí odkaz:
https://doaj.org/article/346acbc4ec1349a88fe4b1e09e59c93c
Autor:
Polona Žigon, Katja Perdan Pirkmajer, Matija Tomšič, Tanja Kveder, Borut Božič, Snežna Sodin Šemrl, Saša Čučnik, Aleš Ambrožič
Publikováno v:
Journal of Immunology Research, Vol 2015 (2015)
Objective. To determine the prevalence and clinical association of anti-phosphatidylserine/prothrombin antibodies (aPS/PT) in patients with a history of pregnancy complications relevant to antiphospholipid syndrome (APS). Materials and Methods. Two h
Externí odkaz:
https://doaj.org/article/fdd44ff8a4df433d9074145b19320c45
Autor:
Andrej Artenjak, Adrijana Leonardi, Igor Križaj, Aleš Ambrožič, Snezna Sodin-Semrl, Borut Božič, Saša Čučnik
Publikováno v:
Journal of Immunology Research, Vol 2014 (2014)
Patient biological material for isolation of β2-glycoprotein I (β2GPI) and high avidity IgG anti-β2-glycoprotein I antibodies (HAv anti-β2GPI) dictates its full utilization. The aim of our study was to evaluate/improve procedures for isolation of
Externí odkaz:
https://doaj.org/article/c42af89d40d24fda8c9298a64fd65c1d
Autor:
Polona Žigon, Saša Čučnik, Aleš Ambrožič, Tanja Kveder, Snežna Sodin Šemrl, Blaž Rozman, Borut Božič
Publikováno v:
Clinical and Developmental Immunology, Vol 2013 (2013)
Antiprothrombin antibodies, measured with phosphatidylserine/prothrombin complex (aPS/PT) ELISA, have been reported to be associated with antiphospholipid syndrome (APS). They are currently being evaluated as a potential classification criterion for
Externí odkaz:
https://doaj.org/article/5d44f113c3364c6b84413db08e08b55e
Publikováno v:
Slovenian Medical Journal. :1-5
V Sloveniji kljub pomanjkanju revmatologov in s tem daljšimi čakalnimi dobami revmatološkim bolnikom zagotavljamo sodobno obravnavo, ki je primerljiva z delom v najbolj priznanih svetovnih ustanovah. Da visoko raven obravnave tudi vprihodnosti ohr